These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Diphenylhydantoin-induced pure red cell aplasia. Rusia U; Malhotra P; Joshi P J Indian Med Assoc; 2006 Jan; 104(1):34-6. PubMed ID: 16850864 [TBL] [Abstract][Full Text] [Related]
12. Reversible pure red cell aplasia associated with diphenylhydantoin therapy. Kueh YK; Yeo TC; Choo MH Ann Acad Med Singap; 1991 May; 20(3):407-9. PubMed ID: 1929190 [TBL] [Abstract][Full Text] [Related]
13. Apparently normal phenytoin metabolism in a patient with phenytoin-induced rash and lymphadenopathy. Maguire JH; Wettrell G; Rane A Br J Clin Pharmacol; 1987 Oct; 24(4):554-7. PubMed ID: 3689636 [TBL] [Abstract][Full Text] [Related]
14. [Lymphadenopathy in phenytoin treatment (author's transl)]. Seyfeddinipur N Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005 [TBL] [Abstract][Full Text] [Related]
18. Mucocutaneous lymph node syndrome in an adult receiving diphenylhydantoin. Anderson VM; Bauer HM; Kelly AP Cutis; 1979 Apr; 23(4):493-8. PubMed ID: 428254 [TBL] [Abstract][Full Text] [Related]
19. Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature. Recker RR; Hynes HE Arch Intern Med; 1969 Apr; 123(4):445-7. PubMed ID: 5781455 [No Abstract] [Full Text] [Related]
20. [Diphenylhydantoin-induced pure red cell aplasia after neurological surgery: report of two cases]. Tanaka S; Toujou H; Tara M; Uetsuhara K No Shinkei Geka; 2000 Aug; 28(8):713-7. PubMed ID: 11002494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]